Affinity DataKi: 3nMAssay Description:Binding affinity to WDR5 expressed in pLysS cells by optimized fluorescent polarization based competitive binding assayMore data for this Ligand-Target Pair
Affinity DataKi: 20nMAssay Description:Binding affinity to WDR5 expressed in pLysS cells by optimized fluorescent polarization based competitive binding assayMore data for this Ligand-Target Pair
Affinity DataKi: 20nMAssay Description:Binding affinity to WDR5 expressed in pLysS cells by optimized fluorescent polarization based competitive binding assayMore data for this Ligand-Target Pair
Affinity DataKi: 30nMAssay Description:Binding affinity to WDR5 expressed in pLysS cells by optimized fluorescent polarization based competitive binding assayMore data for this Ligand-Target Pair
Affinity DataKi: 80nMAssay Description:Binding affinity to WDR5 expressed in pLysS cells by optimized fluorescent polarization based competitive binding assayMore data for this Ligand-Target Pair
Affinity DataKi: 90nMAssay Description:Binding affinity to WDR5 expressed in pLysS cells by optimized fluorescent polarization based competitive binding assayMore data for this Ligand-Target Pair
Affinity DataKi: 120nMAssay Description:Binding affinity to WDR5 expressed in pLysS cells by optimized fluorescent polarization based competitive binding assayMore data for this Ligand-Target Pair
Affinity DataKi: 150nMAssay Description:Binding affinity to WDR5 expressed in pLysS cells by optimized fluorescent polarization based competitive binding assayMore data for this Ligand-Target Pair
Affinity DataKi: 160nMAssay Description:Binding affinity to WDR5 expressed in pLysS cells by optimized fluorescent polarization based competitive binding assayMore data for this Ligand-Target Pair
Affinity DataKi: 160nMAssay Description:Binding affinity to WDR5 expressed in pLysS cells by optimized fluorescent polarization based competitive binding assayMore data for this Ligand-Target Pair
Affinity DataKi: 200nMAssay Description:Binding affinity to WDR5 expressed in pLysS cells by optimized fluorescent polarization based competitive binding assayMore data for this Ligand-Target Pair
Affinity DataKi: 1.60E+3nMAssay Description:Binding affinity to WDR5 expressed in pLysS cells by optimized fluorescent polarization based competitive binding assayMore data for this Ligand-Target Pair
Affinity DataKi: 3.20E+3nMAssay Description:Binding affinity to WDR5 expressed in pLysS cells by optimized fluorescent polarization based competitive binding assayMore data for this Ligand-Target Pair
Affinity DataKi: 6.30E+3nMAssay Description:Binding affinity to WDR5 expressed in pLysS cells by optimized fluorescent polarization based competitive binding assayMore data for this Ligand-Target Pair
Affinity DataKi: 6.50E+3nMAssay Description:Binding affinity to WDR5 expressed in pLysS cells by optimized fluorescent polarization based competitive binding assayMore data for this Ligand-Target Pair
Affinity DataKi: 7.30E+3nMAssay Description:Binding affinity to WDR5 expressed in pLysS cells by optimized fluorescent polarization based competitive binding assayMore data for this Ligand-Target Pair
Affinity DataKi: 9.00E+3nMAssay Description:Binding affinity to WDR5 expressed in pLysS cells by optimized fluorescent polarization based competitive binding assayMore data for this Ligand-Target Pair
Affinity DataKi: 1.50E+4nMAssay Description:Binding affinity to WDR5 expressed in pLysS cells by optimized fluorescent polarization based competitive binding assayMore data for this Ligand-Target Pair
Affinity DataKi: 1.51E+4nMAssay Description:Binding affinity to WDR5 expressed in pLysS cells by optimized fluorescent polarization based competitive binding assayMore data for this Ligand-Target Pair
Affinity DataKi: 1.56E+4nMAssay Description:Binding affinity to WDR5 expressed in pLysS cells by optimized fluorescent polarization based competitive binding assayMore data for this Ligand-Target Pair
Affinity DataKi: 2.70E+4nMAssay Description:Binding affinity to WDR5 expressed in pLysS cells by optimized fluorescent polarization based competitive binding assayMore data for this Ligand-Target Pair
Affinity DataKi: 2.73E+4nMAssay Description:Binding affinity to WDR5 expressed in pLysS cells by optimized fluorescent polarization based competitive binding assayMore data for this Ligand-Target Pair
Affinity DataKi: >5.00E+4nMAssay Description:Binding affinity to WDR5 expressed in pLysS cells by optimized fluorescent polarization based competitive binding assayMore data for this Ligand-Target Pair
Affinity DataKi: >5.00E+4nMAssay Description:Binding affinity to WDR5 expressed in pLysS cells by optimized fluorescent polarization based competitive binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 1nMAssay Description:Binding affinity to WDR5 expressed in pLysS cells after 24 hrs by optimized fluorescent polarization based saturation binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 6nMAssay Description:Binding affinity to WDR5 expressed in pLysS cells by optimized fluorescent polarization based competitive binding assayMore data for this Ligand-Target Pair
Target17-beta-hydroxysteroid dehydrogenase type 2(Homo sapiens (Human))
Bayer Research Center
Curated by ChEMBL
Bayer Research Center
Curated by ChEMBL
Affinity DataIC50: 10nMAssay Description:Inhibition of human recombinant 17beta-HSD2More data for this Ligand-Target Pair
Affinity DataIC50: 14nMAssay Description:Binding affinity to WDR5 expressed in pLysS cells after 24 hrs by optimized fluorescent polarization based saturation binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 20nMAssay Description:Binding affinity to WDR5 expressed in pLysS cells by optimized fluorescent polarization based competitive binding assayMore data for this Ligand-Target Pair
Target17-beta-hydroxysteroid dehydrogenase type 2(Homo sapiens (Human))
Bayer Research Center
Curated by ChEMBL
Bayer Research Center
Curated by ChEMBL
Affinity DataIC50: 30nMAssay Description:Inhibition of human recombinant 17beta-HSD2More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor delta(Homo sapiens (Human))
Bayer Pharmaceuticals
Curated by ChEMBL
Bayer Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 30nMAssay Description:Activity at human PPARdelta expressed in CV1 cells by GAL4 transactivation assayMore data for this Ligand-Target Pair
Target17-beta-hydroxysteroid dehydrogenase type 2(Homo sapiens (Human))
Bayer Research Center
Curated by ChEMBL
Bayer Research Center
Curated by ChEMBL
Affinity DataIC50: 30nMAssay Description:Inhibition of human recombinant 17beta-HSD2More data for this Ligand-Target Pair
Target17-beta-hydroxysteroid dehydrogenase type 2(Homo sapiens (Human))
Bayer Research Center
Curated by ChEMBL
Bayer Research Center
Curated by ChEMBL
Affinity DataIC50: 30nMAssay Description:Inhibition of estradiol to estrone conversion in MG63 cellsMore data for this Ligand-Target Pair
Target17-beta-hydroxysteroid dehydrogenase type 2(Homo sapiens (Human))
Bayer Research Center
Curated by ChEMBL
Bayer Research Center
Curated by ChEMBL
Affinity DataIC50: 40nMAssay Description:Inhibition of human recombinant 17beta-HSD2More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor delta(Homo sapiens (Human))
Bayer Pharmaceuticals
Curated by ChEMBL
Bayer Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 49nMAssay Description:Activity at human PPARdelta expressed in CV1 cells by GAL4 transactivation assayMore data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor delta(Homo sapiens (Human))
Bayer Pharmaceuticals
Curated by ChEMBL
Bayer Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 56nMAssay Description:Activity at human PPARdelta expressed in CV1 cells by GAL4 transactivation assayMore data for this Ligand-Target Pair
Target17-beta-hydroxysteroid dehydrogenase type 2(Homo sapiens (Human))
Bayer Research Center
Curated by ChEMBL
Bayer Research Center
Curated by ChEMBL
Affinity DataIC50: 60nMAssay Description:Inhibition of human recombinant 17beta-HSD2More data for this Ligand-Target Pair
Target17-beta-hydroxysteroid dehydrogenase type 2(Homo sapiens (Human))
Bayer Research Center
Curated by ChEMBL
Bayer Research Center
Curated by ChEMBL
Affinity DataIC50: 60nMAssay Description:Inhibition of estradiol to estrone conversion in MG63 cellsMore data for this Ligand-Target Pair
Target17-beta-hydroxysteroid dehydrogenase type 2(Homo sapiens (Human))
Bayer Research Center
Curated by ChEMBL
Bayer Research Center
Curated by ChEMBL
Affinity DataIC50: 60nMAssay Description:Inhibition of human recombinant 17beta-HSD2More data for this Ligand-Target Pair
Target17-beta-hydroxysteroid dehydrogenase type 2(Homo sapiens (Human))
Bayer Research Center
Curated by ChEMBL
Bayer Research Center
Curated by ChEMBL
Affinity DataIC50: 60nMAssay Description:Inhibition of human recombinant 17beta-HSD2More data for this Ligand-Target Pair
Target17-beta-hydroxysteroid dehydrogenase type 2(Homo sapiens (Human))
Bayer Research Center
Curated by ChEMBL
Bayer Research Center
Curated by ChEMBL
Affinity DataIC50: 70nMAssay Description:Inhibition of human recombinant 17beta-HSD2More data for this Ligand-Target Pair
Affinity DataIC50: 80nMAssay Description:Binding affinity to WDR5 expressed in pLysS cells by optimized fluorescent polarization based competitive binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 80nMAssay Description:Binding affinity to WDR5 expressed in pLysS cells by optimized fluorescent polarization based competitive binding assayMore data for this Ligand-Target Pair
Target17-beta-hydroxysteroid dehydrogenase type 2(Homo sapiens (Human))
Bayer Research Center
Curated by ChEMBL
Bayer Research Center
Curated by ChEMBL
Affinity DataIC50: 90nMAssay Description:Inhibition of estradiol to estrone conversion in MG63 cellsMore data for this Ligand-Target Pair
Target17-beta-hydroxysteroid dehydrogenase type 2(Homo sapiens (Human))
Bayer Research Center
Curated by ChEMBL
Bayer Research Center
Curated by ChEMBL
Affinity DataIC50: 100nMAssay Description:Inhibition of estradiol to estrone conversion in MG63 cellsMore data for this Ligand-Target Pair
Target17-beta-hydroxysteroid dehydrogenase type 2(Homo sapiens (Human))
Bayer Research Center
Curated by ChEMBL
Bayer Research Center
Curated by ChEMBL
Affinity DataIC50: 100nMAssay Description:Inhibition of human recombinant 17beta-HSD2More data for this Ligand-Target Pair
Target17-beta-hydroxysteroid dehydrogenase type 2(Homo sapiens (Human))
Bayer Research Center
Curated by ChEMBL
Bayer Research Center
Curated by ChEMBL
Affinity DataIC50: 120nMAssay Description:Inhibition of human recombinant 17beta-HSD2More data for this Ligand-Target Pair
Target17-beta-hydroxysteroid dehydrogenase type 2(Homo sapiens (Human))
Bayer Research Center
Curated by ChEMBL
Bayer Research Center
Curated by ChEMBL
Affinity DataIC50: 120nMAssay Description:Inhibition of human recombinant 17beta-HSD2More data for this Ligand-Target Pair
Target17-beta-hydroxysteroid dehydrogenase type 2(Homo sapiens (Human))
Bayer Research Center
Curated by ChEMBL
Bayer Research Center
Curated by ChEMBL
Affinity DataIC50: 140nMAssay Description:Inhibition of human recombinant 17beta-HSD2More data for this Ligand-Target Pair
Target17-beta-hydroxysteroid dehydrogenase type 2(Homo sapiens (Human))
Bayer Research Center
Curated by ChEMBL
Bayer Research Center
Curated by ChEMBL
Affinity DataIC50: 140nMAssay Description:Inhibition of human recombinant 17beta-HSD2More data for this Ligand-Target Pair